PYA Waltman Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
PYA Waltman Capital's ABBV Position: Q3 2026 in Review
PYA Waltman Capital increased its AbbVie (ABBV) stake by 12% in Q3 2026, buying an estimated $871K and bringing the position to 32,241 shares worth $8.43M. The position accounts for 1.97% of the portfolio, ranked #16.
PYA Waltman Capital first reported a position in ABBV in Q4 2021 and has held it in 20 quarters since. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- PYA Waltman Capital held 32,241 shares of AbbVie worth $8.43M as of Q3 2026.
- PYA Waltman Capital bought 3,397 AbbVie shares in Q3 2026, an estimated $871K.
- AbbVie made up 1.97% of PYA Waltman Capital's portfolio in Q3 2026, its #16 holding.
- PYA Waltman Capital first reported a position in AbbVie in Q4 2021 and has held it in 20 quarters since.
- 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on PYA Waltman Capital's 13F filing for Q3 2026, filed 16 Nov 2026.